EMEA deltog fortsat aktivt i de internationale harmoniseringskonferencer for henholdsvis humanmedicinske lægemidler og veterinærlægemidler (ICH - og VICH- processerne).
The EU institutions are also looking at other transparency measures as part of the review of the Community pharmaceutical legislation.